Literature DB >> 16107913

The validity of diagnosing chronic obstructive pulmonary disease from a large administrative database.

Yves Lacasse1, Victor M Montori, Claude Lanthier, Francois Maltis.   

Abstract

BACKGROUND: Health authorities create and maintain administrative databases. Despite the potential advantages of these databases, the validity of the information they include must be considered.
OBJECTIVE: To examine the validity of diagnosing chronic obstructive pulmonary disease (COPD) from a large administrative database.
METHODS: Physician services and prescription claims data related to COPD and asthma were extracted from the Quebec universal medical insurance register (Régie de l'assurance-maladie du Québec; RAMQ) from the period of April 1, 1994 to March 31, 1999. Before obtaining the data, criteria for the validity of the COPD diagnosis in the database were formulated based on the epidemiology of COPD in the province. The extent to which the database satisfied these criteria are described within the present paper.
RESULTS: For patients aged 65 years or older, COPD was two times more prevalent in the RAMQ database than in the 1994/1995 National Population Health Survey. One in three patients with a RAMQ-diagnosis of COPD also had a RAMQ-diagnosis of asthma, and 47% of patients aged 65 years or older with a RAMQ-diagnosis of COPD did not fill any prescription for beta-2-agonists. In addition, 42% of patients with a RAMQ-diagnosis of COPD who never had a RAMQ-diagnosis of asthma appeared only once with that diagnosis in the database. Of all patients aged 65 years or older with a RAMQ-diagnosis of COPD, 37% and 23% met the operational definitions of 'possible COPD' and 'probable COPD', respectively.
CONCLUSIONS: Most RAMQ-diagnoses of COPD lack validity; therefore, the validity of database diagnoses should be routinely ascertained before using administrative databases in clinical and health services research.

Entities:  

Mesh:

Year:  2005        PMID: 16107913     DOI: 10.1155/2005/567975

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  19 in total

1.  Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.

Authors:  Jean Lachaine; Gourab De; Vanja Sikirica; Judy Van Stralen; Paul Hodgkins; Hongbo Yang; Julie Heroux; Leila Ben Amor
Journal:  Can J Psychiatry       Date:  2014-11       Impact factor: 4.356

2.  Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study.

Authors:  Christina J Qian; Janie Coulombe; Samy Suissa; Pierre Ernst
Journal:  Br J Clin Pharmacol       Date:  2017-05-07       Impact factor: 4.335

3.  A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction.

Authors:  A Afonso; S Schmiedl; C Becker; S Tcherny-Lessenot; P Primatesta; E Plana; P Souverein; Y Wang; J C Korevaar; J Hasford; R Reynolds; M C H de Groot; R Schlienger; O Klungel; M Rottenkolber
Journal:  Eur J Clin Pharmacol       Date:  2016-05-24       Impact factor: 2.953

4.  Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.

Authors:  Eric J Chow; Kara L Cushing-Haugen; Guang-Shing Cheng; Michael Boeckh; Nandita Khera; Stephanie J Lee; Wendy M Leisenring; Paul J Martin; Beth A Mueller; Stephen M Schwartz; K Scott Baker
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

5.  Identifying patients with physician-diagnosed asthma in health administrative databases.

Authors:  Andrea S Gershon; Chengning Wang; Jun Guan; Jovonka Vasilevska-Ristovska; Lisa Cicutto; Teresa To
Journal:  Can Respir J       Date:  2009 Nov-Dec       Impact factor: 2.409

6.  Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease.

Authors:  Jacques Baillargeon; Yue Wang; Yong-Fang Kuo; Holly M Holmes; Gulshan Sharma
Journal:  Am J Med       Date:  2013-05-17       Impact factor: 4.965

7.  The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia.

Authors:  Pat G Camp; Munaza Chaudhry; Howard Platt; Michael Roch; Jeremy Road; Donald Sin; Robert D Levy
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

8.  Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey.

Authors:  Rosa Gini; Paolo Francesconi; Giampiero Mazzaglia; Iacopo Cricelli; Alessandro Pasqua; Pietro Gallina; Salvatore Brugaletta; Daniele Donato; Andrea Donatini; Alessandro Marini; Carlo Zocchetti; Claudio Cricelli; Gianfranco Damiani; Mariadonata Bellentani; Miriam C J M Sturkenboom; Martijn J Schuemie
Journal:  BMC Public Health       Date:  2013-01-09       Impact factor: 3.295

9.  The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease.

Authors:  Colin R Cooke; Min J Joo; Stephen M Anderson; Todd A Lee; Edmunds M Udris; Eric Johnson; David H Au
Journal:  BMC Health Serv Res       Date:  2011-02-16       Impact factor: 2.655

Review 10.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.